External Defibrillators Market Size By Product (Manual External Defibrillator, Automated External Defibrillator {Semi-automated External Defibrillator, Fully-automated External Defibrillator}, Wearable External Cardioverter Defibrillator), By End-use, & Forecast, 2023 – 2032

External Defibrillator Market Size

External Defibrillators Market size was valued at around USD 3.2 billion in 2022 and is estimated to reach over USD 6.7 billion by 2032. The rising prevalence of heart failure, increasing advancements in product technology, surging incidence of sudden cardiac arrest cases, and supportive initiatives adopted by various governments & public organizations are some of the prime variables driving the market expansion.
 

Similarly, companies operating in the wearable cardiac devices are collaborating with cardiologists  and other healthcare professionals to gain insights into patient needs and to ensure that their products meet medical standards. Such collaborations help in developing effective external defibrillators and establishing credibility within the healthcare community. As a result, technological advancements, customization & personalization, and collaboration with healthcare professionals is augmenting the market revenue.
 

An external defibrillator is a medical device designed to deliver an electric shock to the heart in order to restore its normal rhythm in cases of life-threatening cardiac arrhythmias, particularly ventricular fibrillation and ventricular tachycardia. These abnormal rhythms can prevent the heart from effectively pumping blood, potentially leading to cardiac arrest and death. There are different types of external defibrillators, including automated external defibrillators (AEDs) commonly found in public spaces, such as airports, malls, and public buildings. These AEDs are designed to be user-friendly and can provide verbal instructions to guide even untrained bystanders through the process of delivering a shock.
 

Product failure and product recall is one of the major factors that may hinder the market progress. Certain manufacturing defects enable moisture to saturate inside the external defibrillator and result in short-circuit when the device delivers high voltage shocks. This leads to the patients experiencing less shock than intended or may not receive a shock at all and in certain cases the device fails to respond to check in, and issue battery alerts. Such product failure leads to serious patient outcomes, thereby leading to withdrawal of product from the market.

Further, wearable defibrillators typically use sensors or electrodes to monitor the wearer's heart rhythm. Malfunctions in these sensors or electrodes, such as poor contact with the skin or faulty wiring, can result in inaccurate readings or failure to detect abnormal heart rhythms. FDA received reports of two deaths and a number of injuries. This defibrillator recall was intended to prevent a potentially deadly malfunction. Thus, product recall and failure of external defibrillators may negatively impact the industry demand.
 

COVID-19 Impact

The onset of the COVID-19 pandemic was an unprecedented event impacting the public health and led to an incremental surge in the number of hospitalizations. The subsequent travel restrictions and supply chain challenges had led to substantial disruptions in availability & access to wide range of healthcare services. The COVID-19 pandemic also had a detrimental impact on the medical ecosystem, pushing widespread reallocation of healthcare personnel. The COVID-19 patients were prioritized that negatively influenced other medical practices, including specialty cardiovascular practices. This led to the delay in several procedures including cardiovascular procedures.
 

However, there has been considerable rise in demand for cardiac rhythm management devices despite the pandemic as there was a greater emphasis on having life-saving equipment such as external defibrillators in public spaces, workplaces, and homes. Lockdowns and restrictions on movement had led to a surge in home healthcare services. This trend had led to increased interest in portable external defibrillators that can be used effectively by non-medical professionals in emergencies, allowing for quicker response times and potentially saving more lives. Overall, the abovementioned positive impacts on the external defibrillator demand had augmented the industry revenue.
 

External Defibrillators Market Trends

The rising prevalence of cardiac diseases is one of the major factors propelling the external defibrillators industry growth. Among these, tachycardia is one of the major precursors that promote the disease burden and inflict significant mortality rates. The increasing incidence & prevalence of this conditions, along with its sub-sets such as atrial fibrillation, ventricular tachycardia, supraventricular tachycardia (SVT), and ventricular fibrillation is set to drive the business trends.
 

Moreover, the rising prevalence of cardiac diseases with increasing age further fuels the risk of sudden cardiac arrest. As per the NCBI, the sudden cardiac arrest (SCA) rates surge with age, and the middle-aged adults (35–59 years) contributes to the higher proportion of SCA cases (30–40%). The use of defibrillators during an event of SCA plays a major role in reducing the complications and enhance the clinical outcome. Thus, the increasing incidence of cardiac ailments, in particular the SCA cases, rising number of hospitalizations, and geriatric population would drive the demand for external defibrillators, thereby augment the industry growth.
 

External Defibrillator Market Analysis

Based on product, the external defibrillator market is segmented as manual external defibrillator, automated external defibrillator, and wearable external cardioverter defibrillator. The automated external defibrillator segment held considerable revenue share in 2022 and is projected to expand at 7.5% CAGR to reach USD 2.4 billion by 2032. This segmental growth is majorly attributed to the increasing adoption of these devices, technological advancements driving easy use & automation, and surged prevalence of out-of-hospital cardiac arrest (OHCA). Out-of-hospital cardiac arrest is amongst the significant variables responsible for mortality and morbidity. According to the article published in the American Heart Journals, in 2018, around 50,000 OHCAs were reported in the U.S. External defibrillators are crucial medical devices used in such out-of-hospital cardiac arrest situations.
 

Moreover, automated external defibrillator is designed to be used by non-medical professionals, such as bystanders and first responders. They often provide simple and clear audio & visual instructions, guiding users through the defibrillation process. It allows for immediate intervention in cases of sudden cardiac arrest. Quick defibrillation is crucial to restoring a normal heart rhythm and improving the chances of survival. They are portable devices, making them suitable for a variety of settings, including public spaces, offices, schools, and airports among others. Their compact size ensures they can be easily stored and accessed when needed. Many AED models provide real-time feedback to users during the resuscitation process. This feedback can include guidance on the quality of chest compressions, ensuring that effective CPR is being performed.
 

Based on end-use, the external defibrillator market is segmented as hospitals, prehospital care, ambulatory surgical centers, and others. The hospitals segment held significant share in 2022 and is projected to reach more than USD 2.7 billion by 2032. The soaring use of novel external defibrillators in hospital settings delivering rapid and reliable outcomes is estimated to surge the patient preference for these healthcare facilities. The availability of a broad spectrum of external defibrillators for performing defibrillation treatment with proven accuracy is set to drive product preference in hospitals. Growing admissions with cardiac ailments and growing disease screening initiatives along with the accessibility to board-certified healthcare professionals are some other variables that are augmenting the segment growth positively.
 

Furthermore, the rising disease burden in developed economies with enhanced healthcare infrastructure is projected to stimulate the diagnosis & treatment rate at hospitals. As a result, accessibility to an effective treatment procedure coupled with the rising prevalence of cardiovascular diseases and associated conditions will boost the patient visits to hospitals, thereby propelling the segment revenue.
 

The U.S. external defibrillators market is anticipated to reach more than USD 2.1 billion by 2032. This significant market share is attributed to several factors such as the presence of major industry players, an upsurge in the demand for cardiovascular devices, rise in the prevalence of cardiovascular conditions, and growing number of hospital admissions across the country among others. As per the American Heart Association data 2022, the age adjusted death-rate attributable to cardiovascular diseases was 224.4 per 100,000 population.
 

Additionally, in 2020, coronary heart disease (41.2%) was the leading cause of deaths followed by stroke (17.3%), heart failure (9.2%), etc. in the U.S. These adverse events are anticipated to upsurge the adoption rate for better CVD management. This is further driving the entry of new players in the market that are projected to increase over the forecast timeframe. Moreover, the U.S. is one of the leading nations in terms of heart care initiatives and the government has employed several guidelines to bolster heart care comprising the Million Hearts initiative. These initiatives adopted by the public as well as private organizations would further promote the demand for external defibrillators in the management of certain aspects of heart disease.
 

External defibrillator Market Share

Some of the major market players operating in the external defibrillator market are :

• Abbott Laboratories, Inc.
• Boston Scientific Corporation
• Koninklijke Philips
• Stryker Corporation
• Medtronic plc
• LivaNova PLC
• Asahi Kasei Corporation (ZOLL Medical Corporation) 

Major market players are adopting strategic formulations such as forward integration, new product development, geographical expansion, and research collaborations to garner maximum industry share and promote company growth.
 

External Defibrillator Industry News:

• In June 2020, Philips announced the premarket approval (PMA) for its HeartStart FR3 & HeartStart FRx automated external defibrillators (AEDs) from the Center for Devices and Radiological Health (CDRH) of the U.S. FDA. This product refers to an AED intended to manage ventricular fibrillation (VF) and pulseless ventricular tachycardias (VTs). This regulatory approval helped the company in contributing towards improving the lives of numerous sudden cardiac arrest victims and helped the company to bolster its AED portfolio.
   
• In April 2020, Philips announced resumption of manufacturing and shipping activities concerning external defibrillators in the U.S. after the injunction prohibiting these activities was lifted by the FDA. This development was regarded as a crucial milestone for Philips, as the company had improved the regulatory compliance processes in its ECR business and throughout the company.
   

External defibrillator market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD (million) and volume (Units) from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Product, 2018 - 2032 (USD Million & Units)

• Manual External Defibrillator
• Automated External Defibrillator
  • Semi-Automated External Defibrillator
  • Fully Automated External Defibrillator
•  Wearable External Cardioverter Defibrillator

By End-use, 2018 - 2032 (USD Million)

• Hospitals
• Prehospital care
• Ambulatory Surgical Centers
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Poland
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Indonesia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE